FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
Neuroscience News1d
Schizophrenia Risks Tied to Psychedelic Use
A new study links hallucinogen-related emergency department visits to a 21-fold increased risk of schizophrenia compared to ...
Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia
Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...
Psychedelic use linked to increased risk of schizophrenia, study finds
Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...
Neuroscience News2d
Glial Cells May Influence Depression and Schizophrenia
New research highlights neuroglia (or glia cells) as critical players in mental health, potentially influencing conditions like depression and schizophrenia.